Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/1999
02/05/1999CA2239270A1 Novel phosphoribosyl transferase
02/05/1999CA2238673A1 Novel aminopeptidase
02/04/1999WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
02/04/1999WO1999005502A2 Modulation of multicellular aggregates by solid stress
02/04/1999WO1999005325A1 Methods and compositions for determining species of bacteria and fungi
02/04/1999WO1999005313A2 Method for typing of minor histocompatibility antigen ha-1
02/04/1999WO1999005304A1 Genetically engineered rhodococcus vaccine
02/04/1999WO1999005291A2 Aggrecan degrading metallo proteases
02/04/1999WO1999005282A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus
02/04/1999WO1999005272A1 Use of transcription factor brn-3a
02/04/1999WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
02/04/1999WO1999005174A1 The ha-1 antigen
02/04/1999WO1999005173A1 The ha-1 antigen
02/04/1999WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS
02/04/1999WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS
02/04/1999WO1999005169A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
02/04/1999WO1999005168A1 Mycobacterium strain with modified erp gene and vaccine composition containing same
02/04/1999WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
02/04/1999WO1999004814A1 Combined pharmaceutical preparations containing human monoclonal antibodies for treating chronic hepatitis b
02/04/1999WO1999004813A1 Receptor specific transepithelial transport of therapeutics
02/04/1999WO1999004812A1 Nucleic acid based immunotherapy of chronic hepatitis b infection
02/04/1999WO1999004811A1 Artificial system for the production of infectious human papillomavirus
02/04/1999WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
02/04/1999WO1999004637A1 Methods and compositions for designing vaccines
02/04/1999WO1999004632A1 Induction of immune response to antigens expressed by recombinant adeno-associated virus
02/04/1999WO1998051337A3 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
02/04/1999WO1998050433A3 Human monoclonal antibodies to epidermal growth factor receptor
02/04/1999WO1998050424A3 Human serine protease precursor
02/04/1999DE19733255A1 New GM3-ganglioside-lactone analogues used for active immunisation
02/04/1999CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
02/04/1999CA2300335A1 Induction of immune response to antigens expressed by recombinant adeno-associated virus
02/04/1999CA2298887A1 The ha-1 antigen
02/04/1999CA2298558A1 Genetically engineered rhodococcus vaccine
02/04/1999CA2298107A1 Use of transcription factor brn-3a
02/04/1999CA2298103A1 Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
02/04/1999CA2298063A1 Mycobacterium strain with modified erp gene and vaccine composition containing same
02/04/1999CA2298053A1 Novel estrogen receptor .beta. and isoforms
02/04/1999CA2297907A1 Human estrogen receptor beta
02/04/1999CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
02/04/1999CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
02/04/1999CA2266456A1 Method for typing of minor histocompatibility antigen ha-1
02/04/1999CA2239267A1 Novel compounds
02/03/1999EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33
02/03/1999EP0894862A2 Novel CysS
02/03/1999EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae
02/03/1999EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae
02/03/1999EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae
02/03/1999EP0894857A2 SecA gene from Streptococcus pneumoniae
02/03/1999EP0894856A1 A human sMAD3 splice variant
02/03/1999EP0894855A2 Human I kappa B-beta transcription factor
02/03/1999EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor
02/03/1999EP0894806A1 Novel pheS
02/03/1999EP0894500A1 Streptococcus equi vaccine
02/03/1999EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein
02/03/1999EP0894143A1 Vmp-like sequences of pathogenic borrelia
02/03/1999EP0894135A1 Multivalent and multispecific antigen-binding protein
02/03/1999EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use
02/03/1999EP0894008A1 Method of producing immunogenic products and vaccines
02/03/1999EP0894007A1 Porcine reproductive and respiratory syndrome vaccine
02/03/1999EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY
02/03/1999EP0894005A1 Salmonella typhimurium vaccine
02/03/1999EP0703789B1 Vaccine containing a serine protease
02/03/1999EP0510186B1 Therapeutic uses of melanin
02/03/1999CN1207127A Humanized antibodies to human gp 39, compositions containing and therapeutic use therefor
02/02/1999US5866694 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
02/02/1999US5866690 Human anti-malignin antibody
02/02/1999US5866689 Monoclonal antibodies to GP130 protein
02/02/1999US5866553 Immune protection against infection
02/02/1999US5866541 Genetic engineering
02/02/1999US5866536 Compounds and compositions for delivering active agents
02/02/1999US5866535 Forming antibodies
02/02/1999US5866416 Cell line for propagating receptor binding site-deleted FMDV
02/02/1999US5866403 Homologously recombinant slow growing mycobacteria and uses therefor
02/02/1999US5866401 Vaccine; veterinary medicine
02/02/1999US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus
02/02/1999US5866383 In vitro ligation of foreign DNA into large eukaryotic viruses
02/02/1999US5866373 Polynucleotide encoding a human chemotactic protein
02/02/1999US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.?
02/02/1999US5866369 Amps
02/02/1999US5866368 GreA
02/02/1999US5866367 Gidb
02/02/1999US5866366 gidB
02/02/1999US5866365 Utilizing rnc polypeptides to screen for antibacterial compounds.
02/02/1999US5866351 CD4+ T-lymphocyte proteases and genes encoding said proteases
02/02/1999US5866329 Method and probe for detection of gene associated with liver neoplastic disease
02/02/1999US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
02/02/1999US5866320 Detection antibodies
02/02/1999US5866319 Dna probe capacble of hybridizing with genome
02/02/1999US5866140 Type I surface antigen associated with staphylococcus epidermidis
02/02/1999US5866139 Diagnotic kit
02/02/1999US5866136 Recombinant vaccine
02/02/1999US5866135 Group A streptococcal polysaccharide immunogenic compositions and methods
02/02/1999US5866134 Administering polysaccharide antibody and interleukins
02/02/1999US5866132 Immunogenic oligosaccharide compositions
02/02/1999US5866131 Recombinant vaccine
02/02/1999US5866130 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
02/02/1999US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA
02/02/1999US5866128 Method for the treatment and prevention of gastric and duodenal ulcer
02/02/1999US5866126 Complexing
02/02/1999US5866125 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
1 ... 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 ... 1823